Kieran O’Kane serves as the Chief Commercial Officer of Biodesix since March 2020. Kieran is an experienced commercial leader with deep expertise in oncology. With an academic background in Pharmacology, Kieran has over 25 years in the industry including over 10 product launches globally across pharma, medical device, and clinical diagnostics. Kieran has strong personal motivation to positively impact health outcomes which drives the engine of commercial growth at Biodesix.
Prior to joining Biodesix, Kieran led the Global Diagnostics Marketing team at Nanostring Technologies, a biotechnology company focused on developing cancer diagnostic tools. Kieran held various commercial leadership positions in sales and marketing functions, in addition to managing pricing, reimbursement, health technology appraisal and national payor strategy at companies including Biotheranostics, Cell Therapeutics, Eisai, Cephalon, Bristol-Myers Squibb, and Roche.
Kieran O’Kane
Posted
in
by
Tags: